about
The hypothalamus-pituitary-testis axis in boys during the first six months of life: a comparison of cryptorchidism and hypospadias cases with controlsResponse: the hypothalamus-pituitary-testis axis in cryptorchid boysChildhood papillary thyroid carcinoma with miliary pulmonary metastasesScreening rules for growth to detect celiac disease: a case-control simulation study.Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia.Maternal thyroid autoimmunity during pregnancy and the risk of attention deficit/hyperactivity problems in children: the Generation R StudyIntroduction and management of puberty in girls.Diagnostic approach in children with short stature.Different surgical findings in congenital and acquired undescended testes.Fertility potential in a cohort of 65 men with previously acquired undescended testes.Individualized treatment to optimize eventual cognitive outcome in congenital hypothyroidism.Low urinary iodine excretion during early pregnancy is associated with alterations in executive functioning in children.Peak bone mineral density, lean body mass and fractures.The cryptorchidism prevalence among infants in the general population of Rotterdam, the Netherlands.Successful long-term growth hormone therapy in a girl with haploinsufficiency of the insulin-like growth factor-I receptor due to a terminal 15q26.2->qter deletion detected by multiplex ligation probe amplification.Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy.Soluble Flt1 and placental growth factor are novel determinants of newborn thyroid (dys)function: the generation R study.The effect of oxandrolone on body proportions and body composition in growth hormone-treated girls with Turner syndrome.The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome.A cross-sectional study on biochemical parameters of bone turnover and vitamin d metabolites in healthy dutch children and young adults.Experience in treating congenital hypothyroidism: implications regarding free thyroxine and thyrotropin steady-state concentrations during optimal levothyroxine treatment.Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.Cognitive development in congenital hypothyroidism: is overtreatment a greater threat than undertreatment?Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study.Long-term follow-up of GH-treated girls with Turner syndrome: metabolic consequences.Bone mineral density, growth, and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy only.Maternal thyroid hormone parameters during early pregnancy and birth weight: the Generation R Study.Long-term effects of previous oxandrolone treatment in adult women with Turner syndrome.No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.Influence of timing and dose of thyroid hormone replacement on mental, psychomotor, and behavioral development in children with congenital hypothyroidism.Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.Muscle weakness as presenting symptom of osteogenesis imperfecta.Comparison of body surface area versus weight-based growth hormone dosing for girls with Turner syndrome.Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty.Adult height in children with growth hormone deficiency: a randomized, controlled, growth hormone dose-response trial.Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: a 6-year follow-up study.Karyotype-specific ear and hearing problems in young adults with Turner syndrome and the effect of oxandrolone treatment.Maternal thyroid function during pregnancy and behavioral problems in the offspring: the generation R study.Effect of oxandrolone on glucose metabolism in growth hormone-treated girls with Turner syndrome.Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: the generation R study.
P50
Q23912873-3CFAB3E3-E6F5-4C89-873E-C45D2707AAAFQ23912874-B576F54D-C624-4568-99B9-D95D39638F9AQ28279757-C3BA6956-E079-4B5F-B8B5-1FDBA3709987Q33368842-E54FD2EA-1F6D-4DCD-9A1C-3B27BC28418BQ33829083-8DC07E8E-099C-4FC1-B0C3-EFDDBA7104BDQ34241105-71C7C2B5-551E-47E2-8EE3-D126F99E0D87Q34733059-CB3E527F-CA16-4687-9370-433266B39549Q37604802-6D83E933-C289-4B76-BF54-AAA98443FD6AQ37979965-E2ADA06C-ECEA-4F1B-B99F-249C5AF0D8A8Q39211146-1722106E-B020-48FF-995D-B8C5971CD25CQ39520676-CF230FC6-0121-479F-A8C5-32AFA5F4F00CQ39534574-1DE5E0B7-E3E2-438E-ACCD-CE7629B740D6Q39938326-DE88D7C9-BBB3-456B-BCF4-34DA8FC9BD01Q40401870-003B9D2A-FAB1-4912-B211-F646182945E3Q41939305-E9A4A632-9BD4-4FFC-A963-0169EA171440Q42166162-1C21BB29-F282-433D-9C9B-D28491EC2EA0Q42663435-5AB71452-C76C-4726-9BE4-31B839343832Q43182874-92D8BDF2-B4D0-45AA-AA22-2C38DAA25026Q43201371-6EC53D8C-0B69-4891-8BF9-8E69F32E8D0EQ44020046-11bad85c-4289-1d64-7462-10bc5d01c29cQ44088338-1755F5FF-3366-4DD6-B71A-5B31B0B2D97CQ44357219-1C91FD4A-2634-4D00-AD34-79C47F64AFFFQ45765109-83D49079-2D45-4532-9D62-75CDAE3F00BBQ45898835-E4D1FA76-0FC5-4758-8EDE-01AB6C3380F9Q45977639-783AFCA8-4C98-4EDF-A163-9C2235136F7EQ46085142-6D49774F-543C-4BC8-A522-0CB6678142C7Q46321885-52615CCF-ED3D-4AFE-8A6E-378DFBB47EEBQ46487549-657AAE37-FBFE-4393-90EE-175FE932E16EQ46519204-55CD6330-D37C-4A46-B060-3E9524432984Q46852400-41bbad55-4311-5e9f-3282-266b6b6be5bdQ46915301-FE54AE7F-1860-459B-B4D0-EDF1DE820AF2Q46988961-02B04AEA-252E-456A-846C-9F95BF773025Q47174576-C0E790D2-374F-497D-968D-D90ED2575D51Q47301953-B4DA64BD-71D5-4668-A9F9-6FDCB9800F1EQ47434427-6E00D269-BBE6-4CE5-970A-24C0D86E8713Q48459456-62D70006-1C01-433B-91BF-4CE6118FCBAAQ50354540-856B615C-EF2F-43BD-94F8-E66FC50FE366Q50634622-D322AEB2-BC21-4DD2-8397-65C359285BC5Q51391932-F326F6AF-02B7-43A4-A853-40482563F337Q51906788-E9DE5879-FBE8-49D8-B805-9963E3673EA4
P50
description
researcher
@en
wetenschapper
@nl
name
Sabine M. P. F. de Muinck Keizer-Schrama
@en
Sabine M. P. F. de Muinck Keizer-Schrama
@nl
type
label
Sabine M. P. F. de Muinck Keizer-Schrama
@en
Sabine M. P. F. de Muinck Keizer-Schrama
@nl
altLabel
Sabine de Muinck Keizer-Schrama
@en
prefLabel
Sabine M. P. F. de Muinck Keizer-Schrama
@en
Sabine M. P. F. de Muinck Keizer-Schrama
@nl
P1006
P214
P1006
P108
P214
P31
P4012
P496
0000-0001-6661-381X
P7859
viaf-287317685